In a patient requiring both extracorporeal shock‑wave lithotripsy (ESWL) and an interventional cardiac‑lab (ICL) procedure, how do the dysrhythmia risks compare and what specific preventive measures should be employed for each modality?

ESWL vs ICL Dysrhythmia Risk Comparison

ESWL carries a significantly lower dysrhythmia risk (8.8% incidence, predominantly benign ventricular and atrial extrasystoles) compared to interventional cardiac procedures where electromagnetic interference from radiofrequency ablation and electrocautery poses substantial risks to cardiac rhythm management devices and can induce life-threatening arrhythmias.

Dysrhythmia Risk Profile

ESWL (Extracorporeal Shock Wave Lithotripsy)

The dysrhythmia risk during ESWL is relatively modest and manageable:

• Incidence: 8.8% of patients develop transient dysrhythmias during ungated ESWL 1
• Types: Predominantly ventricular extrasystoles (64%), atrial extrasystoles (32%), and rare bradycardia (4%) 1
• Severity: Almost exclusively benign and self-limiting; treatment interruption was never required 1
• ECG Changes: Post-procedure prolongation of P wave dispersion, QTc, QT dispersion, and Tp-e intervals occur but are transient 2
• Critical Finding: Dysrhythmias occur almost exclusively during renal (not ureteral) stone treatment 1

ICL (Interventional Cardiac Lab) Procedures

The dysrhythmia risks are substantially higher and more complex:

• Electromagnetic Interference (EMI): Radiofrequency ablation and electrocautery create significant EMI that can cause pacemaker inhibition, inappropriate ICD shocks, and device reprogramming 3
• Direct Arrhythmia Induction: RF ablation current can trigger ventricular tachycardia/fibrillation if the current path crosses cardiac tissue 3
• Device-Dependent Patients: Risk of asystole in pacemaker-dependent patients if EMI causes inhibition 4

Specific Preventive Measures

For ESWL

Patients WITHOUT Cardiac Devices:

• Continuous ECG monitoring during procedure 5, 3
• No routine ECG triggering needed - ungated ESWL is safe and efficient 1
• Use ECG triggering only if dysrhythmias develop during treatment (required in <5% of cases) 1
• Have atropine 0.5 mg IV available for rare bradycardia 1

Patients WITH Pacemakers:

• Mandatory cardiologist evaluation pre-procedure 6
• Reprogram dual-chamber pacemakers to single-chamber (VVI) mode 6
• Reprogram rate-responsive pacemakers to non-rate-responsive (VVI) mode 6
• Ensure pacemaker is ≥5 cm from blast path 6
• If lithotripsy system is R-wave triggered, disable atrial pacing preoperatively 3
• Avoid focusing lithotripsy beam near pulse generator 3

Patients WITH ICDs:

• Contralateral ESWL is safe and not contraindicated 7
• Post-procedure device interrogation mandatory to ensure appropriate function 7
• Keep device outside blast path 7

For ICL Procedures

Preoperative Management:

• Interrogate all cardiac devices within 3-6 months before procedure 8
• Document device type, settings, battery status, and pacemaker dependency 8
• Reprogram pacemaker-dependent patients to asynchronous mode (VOO/DOO) 8, 4
• Disable all ICD tachyarrhythmia therapies 3, 4
• Suspend rate-responsive functions 5
• Have temporary pacing and defibrillation equipment immediately available 5

Intraoperative Management:

• Continuous ECG AND peripheral pulse monitoring (pulse oximetry plethysmogram or arterial line) because electrocautery interferes with ECG 3
• Position electrosurgical grounding plate so current pathway does NOT pass through or near device 3
• Use bipolar electrocautery or ultrasonic scalpel instead of monopolar when possible 3
• Use short, intermittent, irregular bursts at lowest feasible energy 3
• For RF ablation: avoid direct catheter contact with pulse generator/leads and keep current path maximally distant 3
• EMI is significant risk when source is <15 cm from device generator 4

Postoperative Management:

• Interrogate and restore device function immediately post-procedure 3, 4
• Reactivate ICD tachytherapies before discharge to unmonitored setting - failure to do so has resulted in sudden death 4
• Continuous cardiac monitoring until device function restored 3

Critical Pitfalls to Avoid

1. ESWL: Do NOT routinely use ECG triggering - it's unnecessary and slows procedure without reducing clinically significant dysrhythmias 1

2. ICL: NEVER discharge a patient with disabled ICD therapies - this has caused preventable deaths 4

3. Both: In pacemaker-dependent patients, loss of pacing from EMI can cause asystole - have backup pacing immediately available 4

4. ICL: Magnet application over ICD only temporarily suspends therapies and may not work in obese/prone patients - reprogramming is more reliable 4

5. ESWL: Dysrhythmias during ureteral stone treatment are exceedingly rare; heightened vigilance needed only for renal stones 1